Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Clinical trial NCT05373472 · COMPLETED
Trial details
- NCT number
- NCT05373472
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-06
- Primary completion
- 2022-09-21
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.